TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 14, 2025

Total Value: $733M (100.0% shares, 0.0% debt)

Holdings (37)

CGON CG ONCOLOGY INC 12.3%
Value $89.88M Shares 3,670,206 Est. Cost $40.67 Unrealized -30.8%
COGT COGENT BIOSCIENCES INC 5.7%
Value $41.72M Shares 6,964,375 Est. Cost $9.05 Unrealized -13.4%
CNTA CENTESSA PHARMACEUTICALS PLC 5.7%
Value $41.57M Shares 2,890,816 Est. Cost $7.22 Unrealized
MLYS MINERALYS THERAPEUTICS INC 5.4%
Value $39.23M Shares 2,470,265 Est. Cost $12.35 Unrealized -6.9%
OCUL OCULAR THERAPEUTIX INC 5.3%
Value $38.99M Shares 5,319,148 Est. Cost $7.10 Unrealized +8.3%
ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES 5.2%
Value $37.85M Shares 6,056,596 Est. Cost $12.76 Unrealized
SVRA SAVARA INC 4.7%
Value $34.24M Shares 12,362,205 Est. Cost $3.73 Unrealized -26.0%
DYN DYNE THERAPEUTICS INC 3.8%
Value $27.72M Shares 2,650,150 Est. Cost $16.62 Unrealized -13.9%
DNTH DIANTHUS THERAPEUTICS INC 3.7%
Value $27.24M Shares 1,501,624 Est. Cost $25.71 Unrealized -14.3%
TYRA TYRA BIOSCIENCES INC 3.7%
Value $26.95M Shares 2,898,103 Est. Cost $12.78 Unrealized +1.3%
XNCR XENCOR INC 3.6%
Value $26.09M Shares 2,452,138 Est. Cost $18.82 Unrealized -12.2%
IRON DISC MEDICINE INC 3.2%
Value $23.1M Shares 465,257 Est. Cost $33.98 Unrealized +63.6%
TOURMALINE BIO INC 3.1%
Value $22.47M Shares 1,477,593 Est. Cost $25.14 Unrealized
CIDARA THERAPEUTICS INC 3.0%
Value $21.67M Shares 1,005,901 Est. Cost $25.94 Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 2.9%
Value $21.04M Shares 5,943,812 Est. Cost $2.53 Unrealized +40.4%
SLNO SOLENO THERAPEUTICS INC 2.7%
Value $19.65M Shares 275,000 Est. Cost $47.87 Unrealized +1.7%
EYPT EYEPOINT PHARMACEUTICALS INC 2.6%
Value $19.36M Shares 3,572,335 Est. Cost $10.51 Unrealized -33.4%
GPCR STRUCTURE THERAPEUTICS INC 2.5%
Value $18.4M Shares 1,063,000 Est. Cost $43.45 Unrealized
UPB UPSTREAM BIO INC 2.3%
Value $17.15M Shares 2,801,763 Est. Cost $22.33 Unrealized -57.2%
RAPT Therapeutics, Inc. 2.2%
Value $15.97M Shares 13,090,200 Est. Cost $1.50 Unrealized
FULC FULCRUM THERAPEUTICS INC 2.1%
Value $15.12M Shares 5,250,000 Est. Cost $7.42 Unrealized -50.5%
ASTRIA THERAPEUTICS INC 2.0%
Value $14.75M Shares 2,761,861 Est. Cost $14.07 Unrealized
TNGX TANGO THERAPEUTICS INC 2.0%
Value $14.71M Shares 10,736,000 Est. Cost $4.64 Unrealized -47.1%
CMPS COMPASS PATHWAYS LTD 1.5%
Value $11.03M Shares 3,858,000 Est. Cost $7.40 Unrealized
KURA KURA ONCOLOGY INC 1.3%
Value $9.396M Shares 1,423,642 Est. Cost $14.54 Unrealized -46.4%
THIRD HARMONIC BIO INC 1.2%
Value $8.694M Shares 2,505,424 Est. Cost $13.43 Unrealized
SLN SILENCE THERAPEUTICS PLC 1.2%
Value $8.555M Shares 3,033,560 Est. Cost $14.21 Unrealized
ADVERUM BIOTECHNOLOGIES INC 1.1%
Value $7.851M Shares 1,796,482 Est. Cost $7.02 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 0.9%
Value $6.691M Shares 2,676,580 Est. Cost $3.41 Unrealized -17.1%
AEROVATE THERAPEUTICS INC 0.8%
Value $5.624M Shares 2,240,809 Est. Cost $15.50 Unrealized
TRDA ENTRADA THERAPEUTICS INC 0.7%
Value $5.288M Shares 584,955 Est. Cost $17.12 Unrealized
MBX MBX BIOSCIENCES INC 0.7%
Value $4.797M Shares 650,000 Est. Cost $22.87 Unrealized -53.8%
AVTX AVALO THERAPEUTICS INC 0.5%
Value $3.869M Shares 483,000 Est. Cost $10.31 Unrealized -26.5%
KOD KODIAK SCIENCES INC 0.4%
Value $3.213M Shares 1,145,538 Est. Cost $4.16 Unrealized +30.6%
NEKTAR THERAPEUTICS 0.4%
Value $2.72M Shares 4,000,000 Est. Cost $0.93 Unrealized
VTYX VENTYX BIOSCIENCES INC 0.0%
Value $364K Shares 316,195 Est. Cost $29.94 Unrealized -94.3%
CABA CABALETTA BIO INC 0.0%
Value $120K Shares 86,795 Est. Cost $3.64 Unrealized -41.5%